| AS | Active surveillance |
| ASA | American Society of Anesthesiology |
| ASCO | American Society of Clinical Oncology |
| AUA | American Urological Association |
| CA | Cryoablation |
| CT | Computed tomography |
| DFS | Disease-free survival |
| DISSRM | Delayed Intervention and Surveillance of Small Kidney Masses |
| DSS | Disease-specific survival |
| EAU | European Association of Urology |
| eGFR | Estimated glomer |
| FDA | Food and Drug Administration |
| FT | Focal therapy |
| IRE | Irreversible electroporation |
| MFS | Metastasis-free survival |
| MWA | Microwave ablation |
| NCCN | National Comprehensive Cancer Network |
| OS | Overall survival |
| PE | Primary efficacy |
| PFS | Progression-free survival |
| PN | Partial nephrectomy |
| RCC | Renal cell carcinoma |
| RFA | Radiofrequency ablation |
| RFS | Recurrence-free survival |
| RN | Radical nephrectomy |
| SE | Secondary efficacy |
| SOC | Standard of care |
| SRM | Small renal masses |
| TA | Thermal ablation |